Prellis Biologics

OverviewSuggest Edit

Prellis Biologics is a company engaged in organ and tissue engineering. It develops a holographic printing system able to match and replicate human organ and tissue structures for research and development and organ transplantation.

HQHayward, CA, US

Latest Updates

Employees (est.) (Sept 2021)36(+6%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Prellis Biologics

Melanie M.

Melanie M.

Founder and CEO
Todd Huffman

Todd Huffman

Vice President Of Product Management
Show more

Prellis Biologics Office Locations

Prellis Biologics has an office in Hayward
Show all (1)

Prellis Biologics Financials and Metrics

Summary Metrics

Founding Date


Prellis Biologics total Funding

$11.1 m

Prellis Biologics latest funding size

$8.74 m

Time since last funding

2 years ago

Prellis Biologics investors

Prellis Biologics's latest funding round in July 2019 was reported to be $8.7 m. In total, Prellis Biologics has raised $11.1 m
Show all financial metrics

Prellis Biologics Operating Metrics

May, 2020

Patents Pending


Product Categories


Trademarks Pending

Show all operating metrics

Prellis Biologics Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Prellis Biologics Online and Social Media Presence

Embed Graph

Prellis Biologics News and Updates

Prellis Bio's Externalized Human Immune System™ rapidly generates 300 SARS-CoV2 antibodies

HAYWARD, Calif. May 19th, 2020--Prellis Biologics, Inc. today announced that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus.

Prellis Biologics Pursues Bioprinted Lymph Nodes for Production of COVID-19 Antibodies

Bay Area bioprinting firm Prellis Biologics is researching the use of bioprinted lymph nodes for the production of SARS-CoV-2 antibodies.

Prellis Biologics launches TissueWorkshop to simplify 3D scaffold design

Prellis Biologics, Inc. is hoping to make the bioprinting process more accessible in order to accelerate research in the field of human tissue engineering. As part of this effort, the company has developed TissueWorkshop, an easy-to-use web-based interface designed for biologists and tissue engineer…


San Francisco biotechnology company Prellis Biologics has launched a web-based platform for the generative design and download of 3D printable tissue scaffolds. Named TissueWorkshop™, the platform has been created to reduce the amount of time required to create such structures, freeing experts from …

Laser Printing Human Organs, A New Kidney In 24 Hours? It’s Closer Than You Think - Part 1 & 2

Melanie Matheu is the CEO of Prellis Biologics. As a scientist, entrepreneur and somebody with a huge vision about the future of organ replacement this podcast literally asks what if we could print life from light.

Prellis Biologics Frequently Asked Questions

  • When was Prellis Biologics founded?

    Prellis Biologics was founded in 2016.

  • Who are Prellis Biologics key executives?

    Prellis Biologics's key executives are Melanie M. and Todd Huffman.

  • How many employees does Prellis Biologics have?

    Prellis Biologics has 36 employees.

  • Who are Prellis Biologics competitors?

    Competitors of Prellis Biologics include Cell Applications, Cellink and OxSyBio.

  • Where are Prellis Biologics offices?

    Prellis Biologics has an office in Hayward.

  • How many offices does Prellis Biologics have?

    Prellis Biologics has 1 office.